title: [Triple screening for trisomy 21: prospective results of 7039 assessments].
authors.affiliation: Division autonome de génétique médicale, CHUV, Lausanne.
authors.forename: G
authors.initials: G
authors.lastname: Pescia
authors.forename: M H
authors.initials: MH
authors.lastname: Dao
authors.forename: D
authors.initials: D
authors.lastname: Weihs
authors.forename: A C
authors.initials: AC
authors.lastname: Gaide
authors.forename: A
authors.initials: A
authors.lastname: Loertscher
authors.forename: P
authors.initials: P
authors.lastname: Hohlfeld
authors.forename: P
authors.initials: P
authors.lastname: Marguerat
authors.forename: H
authors.initials: H
authors.lastname: Nguyen The
authors.forename: F
authors.initials: F
authors.lastname: Paccaud
authors.forename: C
authors.initials: C
authors.lastname: Maillard
mesh_terms: D006063:Chorionic Gonadotropin / Q000097:blood; D004314:Down Syndrome / Q000175:diagnosis*; D004964:Estriol / Q000097:blood; D005260:Female; D006801:Humans; D008423:Maternal Age; D011247:Pregnancy; D011296:Prenatal Diagnosis; D011446:Prospective Studies; D012680:Sensitivity and Specificity; D016216:Ultrasonography, Prenatal; D000509:alpha-Fetoproteins / Q000032:analysis
chemical_list: D006063:Chorionic Gonadotropin; D000509:alpha-Fetoproteins; D004964:Estriol